Data Intern
- Employer
- Legend Biotech
- Location
- Bridgewater, New Jersey
- Posted date
- Oct 20, 2026
View more categories
- Discipline
- Engineering, Information Technology, Science/R&D, Bioinformatics, Business/Data Analytics, Biostatistics
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Pharm Country
By clicking apply, your email address will be shared with the employer.
Job Details
Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy through a portfolio of innovative technologies, including autologous, allogeneic, and in vivo cell therapy approaches. Our research spans chimeric antigen receptor T-cell (CAR-T), T-cell receptor (TCR-T), natural killer (NK) cell-based therapies, and other emerging platforms designed to transform the treatment of serious diseases. From our global network of research and development sites, we are committed to discovering and developing safe, effective, and cutting-edge therapies for patients worldwide.
Legend Biotech entered into a global collaboration agreement with Johnson & Johnson to jointly develop and commercialize CARVYKTI® (ciltacabtagene autoleucel; cilta-cel). Through this strategic partnership, we combine complementary expertise and capabilities to advance innovative immunotherapies for patients living with multiple myeloma.
Legend Biotech is seeking a Data Intern as part of the Information Technology team based in Bridgewater, NJ.
Role Overview
The Data Intern will support the Data & Analytics team in collecting, organizing, analyzing, and visualizing data to enable business decision-making. The intern will gain hands-on experience with enterprise data, business intelligence tools, cloud data platforms, data quality, and documentation within a regulated life sciences environment.
Working with IT, business, and data teams, the intern will contribute to reports, dashboards, data processes, analytics, automation, and AI-enabled initiatives. This opportunity is well suited for a student interested in gaining practical experience in data analytics, data engineering, and business intelligence.
Key Responsibilities
Assist with collecting, cleaning, transforming, and analyzing structured and unstructured data from multiple business systems.
Perform exploratory data analysis to identify trends, patterns, anomalies, and potential data quality issues.
Develop and enhance dashboards, reports, and visualizations using tools such as Microsoft Power BI.
Write SQL queries to retrieve, analyze, and validate data from databases and cloud data platforms.
Support data engineering activities, including data ingestion, transformation, validation, and reconciliation.
Assist with preparing analytics-ready datasets and support the development of data and semantic models.
Support enterprise data platform initiatives using technologies such as Snowflake, Microsoft Azure, Microsoft Fabric, or similar cloud platforms.
Assist with documenting data sources, transformations, lineage, metadata, and business rules.
Perform data quality checks and support the resolution of data inconsistencies.
Support discussions with business stakeholders to understand and document reporting and analytics requirements.
Assist with analytics, automation, and AI-enabled solutions where appropriate.
Participate in testing and validation of reports, dashboards, datasets, and data pipelines.
Prepare technical documentation, presentations, and analytical summaries.
Follow organizational requirements for data privacy, cybersecurity, data governance, and the appropriate handling of confidential information.
Perform other data and analytics-related activities as assigned.
The Data Intern works under the guidance of the Data & Analytics team and may independently perform assigned analysis, prepare reports, document findings, and identify data quality issues. The role may recommend process improvements and highlight risks or issues but does not have authority to make architectural, compliance, financial, or strategic decisions without management approval.
Requirements
Currently pursuing a Bachelor's or Master's degree in:
Data Science
Computer Science
Information Systems
Statistics
Mathematics
Engineering
Bioinformatics
Business Analytics
Ability to break down problems and use data to develop insights.
Desire to learn new data, cloud, analytics, and AI technologies.
Attention to accuracy, completeness, consistency, and traceability of data. ·
Ability to summarize analysis and communicate findings clearly.
Ability to work effectively with technical teams and business stakeholders.
Ability to manage assigned tasks, meet deadlines, and raise issues when needed. ·
Willingness to learn unfamiliar systems, technologies, and business processes.
Basic knowledge of SQL and data analysis concepts.
Coursework, academic projects, or practical experience using Python or a similar programming language.
Familiarity with a data visualization tool such as Power BI, Tableau, or a similar platform is preferred.
Exposure to cloud data platforms or data engineering technologies is a plus.
Coursework or project experience involving machine learning, generative AI, or large language models is a plus.
Familiarity with data governance, data privacy, or regulated environments is a plus.
Interest in biotechnology, pharmaceuticals, healthcare, or life sciences is preferred
#Li-CR1
#Li-Hybrid
Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech.
Work Authorization & Employment Eligibility
Applicants must be authorized to work in the United States. As part of our commitment to maintaining a lawful workforce and ensuring compliance with federal employment regulations, we participate in the E-Verify program. If you are selected for employment, you will be required to complete the Form I-9 process, and your employment eligibility will be verified through E-Verify in accordance with applicable federal law. We are committed to providing a fair, transparent, and welcoming hiring experience for all candidates.
EEO Statement
It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances.
Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company.
For information related to our privacy notice, please review: Legend Biotech Privacy Notice.
Company
Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and gene editing to take the leap.
For two years, Legend Biotech, then known as the “Legend Project,” operated in a room the size of a freight elevator, with the goal of creating a cell therapy for multiple myeloma, a hematological cancer that often relapses and can become refractory. The team produced nanobodies for single-domain antibody drugs and ultimately extended the half-life of the nanobodies with proprietary technologies.
In 2015, Legend’s scientists focused on research for chimeric antigen-receptor T-cells (CAR-T) targeting the BCMA protein, making the biotech one of the first companies in the world to engineer CAR-T cells for the BCMA protein. In 2016, investigator-initiated trials began in China.
In 2017, data from the trials were presented at the American Society for Clinical Oncology (ASCO), which led to a partnership with biopharmaceutical company Janssen Biotech, Inc. to co-develop the anti-BCMA CAR-T, ciltacabtagene autoleucel (cilta-cel). Applications seeking approval of cilta-cel for the treatment of patients with RRMM are currently under regulatory review by several health authorities around the world. CARVYKTI™ (ciltacabtagene autoleucel) was approved by the U.S. Food and Drug Administration in February 2022 and received conditional marketing approval from the European Medicines Agency in May 2022.
Today Legend Biotech is a global, commercial-stage company driven by a passion for patients. We continue to build our pipeline of cell therapy platforms, which includes CAR-T, CAR-NK, CAR-γδ T and non-gene-editing CAR technologies.
Our goal is to bring hope and opportunity to patients and their families by continuing to explore unique technologies.